Cargando…

Current understanding of AD pathophysiology and impact of amyloid‐beta targeted treatments on biomarkers and clinical endpoints

Detalles Bibliográficos
Autores principales:	Petersen, Ronald C., Graf, Ana, Carrillo, Maria C., Weber, Christopher J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	News
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583953/ https://www.ncbi.nlm.nih.gov/pubmed/36284665 http://dx.doi.org/10.1002/trc2.12361

Ejemplares similares

Understanding the Pathophysiology of Cerebral Amyloid Angiopathy
por: Gatti, Laura, et al.
Publicado: (2020)

Physiological Roles of β-amyloid in Regulating Synaptic Function: Implications for AD Pathophysiology
por: Cai, Wenwen, et al.
Publicado: (2022)

Dentists added to PPE portal
Publicado: (2020)

Understanding the Use of Composite Endpoints in Clinical Trials
por: McCoy, C. Eric
Publicado: (2018)

Imaging β amyloid's pore performance
por: Short, Ben
Publicado: (2011)

Peripheral macrophages not ADept at amyloid clearance
por: Jay, Taylor, et al.
Publicado: (2015)

Ltc1 gets added to the ER’s contacts
por: Short, Ben
Publicado: (2015)

Precision mass measurements utilizing beta endpoints
por: Moltz, D M, et al.
Publicado: (1981)

Adding another piece to the retinoblastoma puzzle
por: Blixt, M K E, et al.
Publicado: (2015)

Incidence, Pathophysiology, and Impact of Coronavirus Disease 2019 (COVID-19) on Acute Ischemic Stroke
por: Majmundar, Neil, et al.
Publicado: (2020)

Operationalizing selection criteria for clinical trials in Alzheimer's disease: Biomarker and clinical considerations
por: Petersen, Ronald C., et al.
Publicado: (2023)

Why do anti-amyloid beta antibodies not work? Time to reconceptualize dementia pathophysiology by incorporating astrocyte melatonergic pathway desynchronization from amyloid-beta production
por: Anderson, George
Publicado: (2023)

Coping with brain amyloid: genetic heterogeneity and cognitive resilience to Alzheimer’s pathophysiology
por: Ramanan, Vijay K., et al.
Publicado: (2021)

Dual therapy for Aβ amyloidosis in AD: A successful one-two combo
por: Patel, Tirth K., et al.
Publicado: (2018)

Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as Biomarkers
por: Barba, Lorenzo, et al.
Publicado: (2022)

Amyloid Beta, TNFα and FAIM-L; Approaching New Therapeutic Strategies for AD
por: Carriba, Paulina, et al.
Publicado: (2014)

APC: More than a beta (catenin) blocker
por: Leslie, Mitch
Publicado: (2010)

Understanding the Pathophysiology of Congenital Vestibular Disorders: Current Challenges and Future Directions
por: Peusner, Kenna D., et al.
Publicado: (2021)

Machine learning of brain structural biomarkers for Alzheimer's disease (AD) diagnosis, prediction of disease progression, and amyloid beta deposition in the Japanese population
por: Shiino, Akihiko, et al.
Publicado: (2021)

When alpha meets beta, mast cells get hyper
por: Ong, Michelle Shuling, et al.
Publicado: (2019)

A firmer understanding of muscle fibrosis
por: Short, Ben
Publicado: (2012)

Andrew Ewald: Understanding cellular cooperation
por: Marat, Andrea
Publicado: (2017)

Toward an understanding of the regulation of myofibrillar function
por: Moss, Richard L., et al.
Publicado: (2019)

CERN Enters the Second Year AD
Publicado: (2001)

Microbiome of the Skin and Gut in Atopic Dermatitis (AD): Understanding the Pathophysiology and Finding Novel Management Strategies
por: Kim, Jung Eun, et al.
Publicado: (2019)

Catatonia: Our current understanding of its diagnosis, treatment and pathophysiology
por: Rasmussen, Sean A, et al.
Publicado: (2016)

Current Understanding of Epidemiology, Pathophysiology, and Management of Atypical Femur Fractures
por: Starr, Jessica, et al.
Publicado: (2018)

Lipid oxidation in pathophysiology of atherosclerosis: Current understanding and therapeutic strategies
por: Salekeen, Rahagir, et al.
Publicado: (2022)

Understanding the DisAp-pearance of cilia orientation
por: Short, Ben
Publicado: (2014)

Deafness-associated mutation opens the gate to understanding
por: Sedwick, Caitlin
Publicado: (2018)

Sodium ion unlocks understanding of channel blockade
por: Sedwick, Caitlin
Publicado: (2017)

Biomarkers and cognitive endpoints to optimize trials in Alzheimer's disease
por: Insel, Philip S, et al.
Publicado: (2015)

Alzheimer’s cerebrospinal biomarkers from Lumipulse fully automated immunoassay: concordance with amyloid-beta PET and manual immunoassay in Koreans: CSF AD biomarkers measured by Lumipulse in Koreans
por: Moon, Sohee, et al.
Publicado: (2021)

Amyloid-beta Alzheimer targets — protein processing, lipid rafts, and amyloid-beta pores
por: Arbor, Sage C., et al.
Publicado: (2016)

Editorial: Biomarker Exploration in Neuropsychiatry: Understanding of the Pathophysiology and Therapeutic Implications
por: Cai, Hualin, et al.
Publicado: (2021)

Beta-amyloid imaging with florbetaben
por: Sabri, Osama, et al.
Publicado: (2015)

A Matter Of Degrees: Advancing Our Understanding of Acrylamide
por: Spivey, Angela
Publicado: (2010)

Major progress in understanding progression in chronic myeloid leukemia
por: Radich, Jerry
Publicado: (2015)

'It is essential that dental students have the awareness and understanding of these issues'
por: Westgarth, David
Publicado: (2022)

Plasma amyloid beta 42 is a biomarker for patients with hereditary, but not sporadic, cerebral amyloid angiopathy
por: de Kort, Anna M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r1ahgunv9243dagr7tu5u954m0